Top Markets
#1 Black Phoenix Black Phoenix +166.82%
#2 Islamic Coin Islamic Coin +158.16%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +29.06%
#5 Cryptopia Cryptopia +20.92%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.86%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.84%
#8 Test Test +13.79%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +10.94%
#10 Bluwhale Bluwhale +10.65%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Vitalibis, Inc. Vitalibis, Inc.

Vitalibis, Inc.

VCBDQ
Rank in Stocks #41730
Vitalibis, Inc. is a technology-driven company that specializes in developing... Vitalibis, Inc. is a technology-driven company that specializes in developing and creating phytocannabinoid-rich hemp products, including those infused with cannabidiol (CBD). Beyond these, they also formulate personal care items and nutritional supplements. The company markets and sells these consumer goods directly under its proprietary Vitalibis brand. A key product in their portfolio is a water-soluble, phytocannabinoid-rich hemp powder. Originally established in 2014, the company was initially known as Sheng Ying Entertainment Corp. It subsequently rebranded to Vitalibis, Inc. in February 2018. Its operations are based in Las Vegas, Nevada.
Share Price
$0.0005
Last synced: 2023-08-29
Market Cap
$11.76K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Vitalibis, Inc. (VCBDQ)

Category

Healthcare
P/E ratio for Vitalibis, Inc. (VCBDQ)
P/E ratio as of 2026 TTM: 0
According to Vitalibis, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Vitalibis, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 41.61 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.